Has adherence to treatment guidelines for mid/low rectal cancer affected the management of patients? A monocentric study of 604 consecutive patients.


Journal

Journal of visceral surgery
ISSN: 1878-7886
Titre abrégé: J Visc Surg
Pays: France
ID NLM: 101532664

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 17 3 2019
medline: 18 7 2020
entrez: 17 3 2019
Statut: ppublish

Résumé

In 2006 under the supervision of the French health authorities (HAS), recommendations for clinical practice (RCP) in the management of rectal cancers were first published. The primary objective of this study was to assess the impact of these guidelines on multidisciplinary management in terms of therapeutic strategies based on disease staging and quality indicators for surgical excision. Secondarily, we assessed the impact of the RCPs on postoperative and oncological outcomes. All consecutive patients having undergone curative surgical excision for middle and low (subperitoneal) rectal cancer from 1995 to 2017 in the university hospital of Caen were included in accordance with the relevant French guidelines. They were divided into two groups: before (Gr1) and after (Gr2) 2006. For each group, a chart review was conducted on demographic variables, preoperative rectal tumor features, disease severity variables and quality of surgery variables. Postoperative and oncological outcomes were likewise assessed and compared between the two groups. Six hundred and four patients were included (Gr1, n=266; Gr2, n=338). Compliance with French guidelines significantly improved (i) use of magnetic resonance imaging (P<0.0001) and CT-scan (P<0.0001)]; (ii) organization of multidisciplinary tumor boards (P<0.0001) leading to suitable neo-adjuvant treatment plan classification (P<0.0001). Consequently, compliance improved widespread total mesorectal excision (P<0.0001), sphincter-sparing surgery (P=0,0005), and completeness of curative resection in the specimen (P<0.0001). Although postoperative 90-day mortality was similar, overall postoperative morbidity significantly increased in Gr2 (P<0.0001). Overall (P=0.0005) and disease-free survival (P=0.0016) of patients in Gr2 were significantly prolonged and correlated with a significant reduction in local and distant recurrences. Compliance with the relevant French guidelines improved the quality of multidisciplinary management of patients undergoing curative surgery for subperitoneal rectal cancer. However, further progress is still needed to render accession to the recommendations more comprehensive.

Identifiants

pubmed: 30876923
pii: S1878-7886(19)30001-3
doi: 10.1016/j.jviscsurg.2019.01.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

281-290

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Y Eid (Y)

Service de chirurgie digestive, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France; « ANTICIPE » U1086 Inserm-UCN, équipe « Ligue contre le cancer », centre François-Baclesse, 14032 Caen cedex, France; Unité de formation et de recherche de médecine, 14032 Caen cedex, France. Electronic address: eidyassine@hotmail.fr.

B Menahem (B)

Service de chirurgie digestive, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France; « ANTICIPE » U1086 Inserm-UCN, équipe « Ligue contre le cancer », centre François-Baclesse, 14032 Caen cedex, France; Unité de formation et de recherche de médecine, 14032 Caen cedex, France.

V Bouvier (V)

« ANTICIPE » U1086 Inserm-UCN, équipe « Ligue contre le cancer », centre François-Baclesse, 14032 Caen cedex, France; Registre des tumeurs digestives du Calvados-Pôle recherche, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France.

G Lebreton (G)

Service de chirurgie digestive, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France.

A Thobie (A)

Service de chirurgie digestive, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France; « ANTICIPE » U1086 Inserm-UCN, équipe « Ligue contre le cancer », centre François-Baclesse, 14032 Caen cedex, France; Unité de formation et de recherche de médecine, 14032 Caen cedex, France.

C Bazille (C)

Service d'anatomo-cytopathologie, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France.

M Finochi (M)

Service de chirurgie digestive, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France; Unité de formation et de recherche de médecine, 14032 Caen cedex, France.

A Fohlen (A)

Service de radiologie, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France; CEA, CNRS, ISTCT/CERVOxy group, université de caen-Normandie, Caen, 14000 Basse-Normandie, France.

M P Galais (MP)

Service de pathologie digestive, centre François-Baclesse, Caen, 14000 Basse-Normandie, France.

B Dupont (B)

Service d'hépato-gastro-entérologie, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France.

J Lubrano (J)

Service de chirurgie digestive, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France; Unité de formation et de recherche de médecine, 14032 Caen cedex, France.

O Dejardin (O)

« ANTICIPE » U1086 Inserm-UCN, équipe « Ligue contre le cancer », centre François-Baclesse, 14032 Caen cedex, France; Registre des tumeurs digestives du Calvados-Pôle recherche, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France.

R Morello (R)

Unité de formation et de recherche de médecine, 14032 Caen cedex, France; Unité de biostatistiques et de recherche clinique (UBRC), centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France.

A Alves (A)

Service de chirurgie digestive, centre hospitalier universitaire de Caen, avenue de la Côte-de-Nacre, 14032 Caen cedex, France; « ANTICIPE » U1086 Inserm-UCN, équipe « Ligue contre le cancer », centre François-Baclesse, 14032 Caen cedex, France; Unité de formation et de recherche de médecine, 14032 Caen cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH